Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9659)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2014 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou J, Chng WJ. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia. World J Stem Cells 2014; 6(4): 473-484 [PMID: 25258669 DOI: 10.4252/wjsc.v6.i4.473] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v6/i4/473.htm |
| Number | Citing Articles |
| 1 |
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, Reni Kitte, Sarah Dluczek, Alexander Strauß, André-René Blaudszun, Tetyana Yevsa, Stephan Fricke, Uta Kossatz-Boehlert. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01280
|
| 2 |
Alexander C Lewis, Lev M Kats. Non‐genetic heterogeneity, altered cell fate and differentiation therapy. EMBO Molecular Medicine 2021; 13(3) doi: 10.15252/emmm.202012670
|
| 3 |
Kodappully Sivaraman Siveen, Shahab Uddin, Ramzi M. Mohammad. Targeting acute myeloid leukemia stem cell signaling by natural products. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-016-0571-x
|
| 4 |
Liu Yang, Houyu Zhang, Xue Yang, Ting Lu, Shihui Ma, Hui Cheng, Kuangyu Yen, Tao Cheng. Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659201
|
| 5 |
Karin Bauer, Alexander Hauswirth, Karoline V. Gleixner, Georg Greiner, Johannes Thaler, Peter Bettelheim, Yüksel Filik, Elisabeth Koller, Gregor Hoermann, Philipp B. Staber, Wolfgang R. Sperr, Felix Keil, Peter Valent. BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL. American Journal of Hematology 2024; 99(9): 1721 doi: 10.1002/ajh.27385
|
| 6 |
Ieda Cristina Cunha Ferreira e Fonseca, Felipe Andrés Cordero da Luz, Isadora Akemi Uehara, Marcelo José Barbosa Silva. Cell-adhesion molecules and their soluble forms: Promising predictors of “tumor progression” and relapse in leukemia. Tumor Biology 2018; 40(11): 101042831881152 doi: 10.1177/1010428318811525
|
| 7 |
Xingmei Mu, Chumao Chen, Loujie Dong, Zhaowei Kang, Zhixian Sun, Xijie Chen, Junke Zheng, Yaping Zhang. Immunotherapy in leukaemia. Acta Biochimica et Biophysica Sinica 2023; 55(6): 974 doi: 10.3724/abbs.2023101
|
| 8 |
Seyed Fazel Nabavi, Stefania Bilotto, Gian Luigi Russo, Ilkay Erdogan Orhan, Solomon Habtemariam, Maria Daglia, Kasi Pandima Devi, Monica Rosa Loizzo, Rosa Tundis, Seyed Mohammad Nabavi. Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Cancer and Metastasis Reviews 2015; 34(3): 359 doi: 10.1007/s10555-015-9572-2
|
| 9 |
Yashar Mesbahi, Toby N. Trahair, Richard B. Lock, Patrick Connerty. Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.807266
|
| 10 |
Iris Z. Uras, Gina J. Walter, Ruth Scheicher, Florian Bellutti, Michaela Prchal-Murphy, Anca S. Tigan, Peter Valent, Florian H. Heidel, Stefan Kubicek, Claudia Scholl, Stefan Fröhling, Veronika Sexl. Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6. Blood 2016; 127(23): 2890 doi: 10.1182/blood-2015-11-683581
|
| 11 |
Chen Tian, M. James You, Yong Yu, Lei Zhu, Guoguang Zheng, Yizhuo Zhang. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tumor Biology 2016; 37(6): 7461 doi: 10.1007/s13277-015-4581-x
|
| 12 |
Mingyue Shi, Xiaoyan Dong, Lei Huo, Xiaobin Wei, Fang Wang, Kai Sun. Single Cell Biomedicine. Advances in Experimental Medicine and Biology 2018; 1068: 119 doi: 10.1007/978-981-13-0502-3_10
|
| 13 |
Jayaprakasam Madhumathi, Surapally Sridevi, Rama Shanker Verma. CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide. Stem Cell Research 2017; 19: 65 doi: 10.1016/j.scr.2017.01.001
|
| 14 |
Zhenlin Wang, Chenting Ying, Anke Zhang, Houshi Xu, Yang Jiang, Meiqing Lou. HCK promotes glioblastoma progression by TGFβ signaling. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20200975
|
| 15 |
Jianbiao Zhou, Yvonne Ng, Wee-Joo Chng. ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia. Cellular and Molecular Life Sciences 2018; 75(21): 3931 doi: 10.1007/s00018-018-2895-8
|
| 16 |
Wariya Nirachonkul, Siriporn Ogonoki, Tarika Thumvijit, Supanimit Chiampanichayakul, Pawaret Panyajai, Songyot Anuchapreeda, Singkome Tima, Sawitree Chiampanichayakul. CD123-Targeted Nano-Curcumin Molecule Enhances Cytotoxic Efficacy in Leukemic Stem Cells. Nanomaterials 2021; 11(11): 2974 doi: 10.3390/nano11112974
|
| 17 |
Maximilian Stahl, Tae Kon Kim, Amer M Zeidan. Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities. World Journal of Stem Cells 2016; 8(10): 316-331 doi: 10.4252/wjsc.v8.i10.316
|
| 18 |
Bin Li, Weiyu Zhao, Xinfu Zhang, Junfeng Wang, Xiao Luo, Sharyn D. Baker, Craig T. Jordan, Yizhou Dong. Design, synthesis and evaluation of anti-CD123 antibody drug conjugates. Bioorganic & Medicinal Chemistry 2016; 24(22): 5855 doi: 10.1016/j.bmc.2016.09.043
|
| 19 |
Xuefeng He, Xinyang Zhong, Zijuan Hu, Senlin Zhao, Ping Wei, Dawei Li. An insight into small extracellular vesicles: Their roles in colorectal cancer progression and potential clinical applications. Clinical and Translational Medicine 2020; 10(8) doi: 10.1002/ctm2.249
|
| 20 |
Xing Xing Zhang, Yao Yao Yan, Xiao Ma, Yun Xiao, Cen Cen Lei, Yu Meng Wang, Chao Liu, Quan Wang, Xing Tao Zhang, Wen Dan Cheng, Xin Hua Liu. Discovery of a novel oral type Ⅰ CDK8 inhibitor against acute myeloid leukemia. European Journal of Medicinal Chemistry 2023; 251: 115214 doi: 10.1016/j.ejmech.2023.115214
|
| 21 |
Jianbiao Zhou, Xiao-Lan Li, Zhi-Rong Chen, Wee-Joo Chng. Tumor-derived exosomes in colorectal cancer progression and their clinical applications. Oncotarget 2017; 8(59): 100781 doi: 10.18632/oncotarget.20117
|
| 22 |
Mehrdad Mahalleh, Mahsima Shabani, Elham Rayzan, Nima Rezaei. Reinforcing the Primary Immunotherapy Modulators Against Acute Leukemia; Monoclonal Antibodies in AML. Immunotherapy 2019; 11(18): 1583 doi: 10.2217/imt-2019-0043
|
| 23 |
Ilaria M. Michelozzi, Efstratios Kirtsios, Alice Giustacchini. Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success. Cancers 2021; 13(11): 2816 doi: 10.3390/cancers13112816
|
| 24 |
Maria Paprocka, Aleksandra Bielawska‐Pohl, Joanna Rossowska, Agnieszka Krawczenko, Danuta Duś, Marek Kiełbiński, Olga Haus, Maria Podolak‐Dawidziak, Kazimierz Kuliczkowski. MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients. European Journal of Haematology 2017; 99(5): 415 doi: 10.1111/ejh.12938
|
| 25 |
Jing Chen, Hulai Wei, Jie Cheng, Bei Xie, Bei Wang, Juan Yi, Baoying Tian, Zhuan Liu, Feifei Wang, Zhewen Zhang. Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL‑60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells. Oncology Letters 2017; doi: 10.3892/ol.2017.7353
|
| 26 |
Fernanda Marconi Roversi, Fernando Vieira Pericole, João Agostinho Machado-Neto, Adriana da Silva Santos Duarte, Ana Leda Longhini, Flávia Adolfo Corrocher, Bruna Palodetto, Karla Priscila Ferro, Renata Giardini Rosa, Mariana Ozello Baratti, Sergio Verjovski-Almeida, Fabiola Traina, Alessio Molinari, Maurizio Botta, Sara Teresinha Olalla Saad. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(2): 450 doi: 10.1016/j.bbadis.2016.11.013
|
| 27 |
Suresh Kumar Prajapati, Neha Kumari, Doulat Bhowmik, Reeshu Gupta. Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia. Annals of Hematology 2024; 103(11): 4375 doi: 10.1007/s00277-024-05963-x
|
| 28 |
Qing Ji, Ya-hui Ding, Yue Sun, Yu Zhang, Hui-er Gao, He-nan Song, Ming Yang, Xiao-lei Liu, Zi-xiang Zhang, Ying-hui Li, Ying-dai Gao. Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells. Oncotarget 2016; 7(40): 65012 doi: 10.18632/oncotarget.11342
|
| 29 |
Marlon Arnone, Martina Konantz, Pauline Hanns, Anna M. Paczulla Stanger, Sarah Bertels, Parimala Sonika Godavarthy, Maximilian Christopeit, Claudia Lengerke. Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity. Cancers 2020; 12(12): 3742 doi: 10.3390/cancers12123742
|
| 30 |
Jianbiao Zhou, Ying Qing Ching, Wee-Joo Chng. Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target. Oncotarget 2015; 6(8): 5490 doi: 10.18632/oncotarget.3545
|
| 31 |
Azin Samimi, Mohammad Javad Khodayar, Hadis Alidadi, Elahe Khodadi. The Dual Role of ROS in Hematological Malignancies: Stem Cell Protection and Cancer Cell Metastasis. Stem Cell Reviews and Reports 2020; 16(2): 262 doi: 10.1007/s12015-019-09949-5
|
| 32 |
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia. Haematologica 2019; 105(9): 2286 doi: 10.3324/haematol.2019.230482
|
| 33 |
BRANDON J kale, Nathaniel R Wilson, Naveen Pemmaraju. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. 2024; : 205 doi: 10.1016/B978-0-323-79833-4.00014-0
|
| 34 |
Jianbiao Zhou, Chonglei Bi, Ying Qing Ching, Jing-Yuan Chooi, Xiao Lu, Jessie Yiying Quah, Sabrina Hui-Min Toh, Zit-Liang Chan, Tuan Zea Tan, Phyllis SY Chong, Wee-Joo Chng. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0507-y
|
| 35 |
Bettina Wingelhofer, Barbara Maurer, Elizabeth C. Heyes, Abbarna A. Cumaraswamy, Angelika Berger-Becvar, Elvin D. de Araujo, Anna Orlova, Patricia Freund, Frank Ruge, Jisung Park, Gary Tin, Siawash Ahmar, Charles-Hugues Lardeau, Irina Sadovnik, Dávid Bajusz, György Miklós Keserű, Florian Grebien, Stefan Kubicek, Peter Valent, Patrick T. Gunning, Richard Moriggl. Pharmacologic inhibition of STAT5 in acute myeloid leukemia. Leukemia 2018; 32(5): 1135 doi: 10.1038/s41375-017-0005-9
|
| 36 |
Noureldien H.E. Darwish, Thangirala Sudha, Kavitha Godugu, Osama Elbaz, Hasan A. Abdelghaffar, Emad E.A. Hassan, Shaker A. Mousa. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1. Oncotarget 2016; 7(36): 57811 doi: 10.18632/oncotarget.11063
|
| 37 |
Yunlu Jia, Wee-Joo Chng, Jianbiao Zhou. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0757-y
|
| 38 |
Noureldien H. E. Darwish, Thangirala Sudha, Kavitha Godugu, Dhruba J. Bharali, Osama Elbaz, Hasan A. Abd El-ghaffar, Emad Azmy, Nahla Anber, Shaker A. Mousa. Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. Molecules 2019; 24(11): 2103 doi: 10.3390/molecules24112103
|
| 39 |
Hongwei Luo, Yingchun Zhang, Nan Hu, Yancheng He, Chengcheng He. Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.715840
|
| 40 |
Jianbiao Zhou, Wee-Joo Chng. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1365330
|
| 41 |
Fu-rong Liu, Hui Jin, Yin Wang, Chen Chen, Ming Li, Sheng-jun Mao, Qiantao Wang, Hui Li. Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia. Drug Delivery 2017; 24(1): 882 doi: 10.1080/10717544.2017.1333170
|
| 42 |
Jie Shen, Zhiguo Lu, Jianze Wang, Tianlu Zhang, Jun Yang, Yan Li, Guiying Liu, Xin Zhang. Advances of Nanoparticles for Leukemia Treatment. ACS Biomaterials Science & Engineering 2020; 6(12): 6478 doi: 10.1021/acsbiomaterials.0c01040
|
| 43 |
Hongbing Ma, Iyer Swaminathan Padmanabhan, Simrit Parmar, Yuping Gong. Targeting CLL-1 for acute myeloid leukemia therapy. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0726-5
|
| 44 |
Jiahui Li, Bin Tang, Ying Miao, Guihong Li, Zhenliang Sun. Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression. Oncology Reports 2023; 50(6) doi: 10.3892/or.2023.8645
|
| 45 |
Cathy C Zhang, Zhengming Yan, Bernadette Pascual, Amy Jackson-Fisher, Donghui Stephen Huang, Qing Zong, Mark Elliott, Conglin Fan, Nanni Huser, Joseph Lee, Matthew Sung, Puja Sapra. Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia. Neoplasia 2018; 20(1): 1 doi: 10.1016/j.neo.2017.10.008
|
| 46 |
Naghmeh Haddadi, Mehrzad Mirzania, Hadi Ansarihadipour. Syringic acid Attenuates Oxidative Stress in Plasma and Peripheral Blood Mononuclear Cells of Patients with Acute Myeloid Leukemia. Nutrition and Cancer 2023; 75(3): 1038 doi: 10.1080/01635581.2023.2170432
|
| 47 |
Amir Amanzadeh, Fatemeh Heidarnejad, Meghdad Abdollahpour-Alitappeh, Vahid Molla-Kazemiha, Shamsi Yari, Alireza Hadizadeh-Tasbiti, Mahdi Habibi-Anbouhi, Mohsen Abolhassani, Mohammad Ali Shokrgozar. Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia. Human Antibodies 2018; 26(1): 7 doi: 10.3233/HAB-170315
|
| 48 |
Jianbiao Zhou, Zit-Liang Chan, Chonglei Bi, Xiao Lu, Phyllis S.Y. Chong, Jing-Yuan Chooi, Lip-Lee Cheong, Shaw-Cheng Liu, Ying Qing Ching, Yafeng Zhou, Motomi Osato, Tuan Zea Tan, Chin Hin Ng, Siok-Bian Ng, Shi Wang, Qi Zeng, Wee-Joo Chng. LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell–like Transcriptional Program in AML. Molecular Cancer Research 2017; 15(3): 294 doi: 10.1158/1541-7786.MCR-16-0275-T
|
| 49 |
Yaru Sheng, Zhongzhong Ji, Huifang Zhao, Jinming Wang, Chaping Cheng, Weimin Xu, Xue Wang, Yuman He, Kaiyuan Liu, Li Li, Thibault Voeltzel, Veronique Maguer‐Satta, Wei‐Qiang Gao, Helen He Zhu. Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells. Cell Proliferation 2019; 52(4) doi: 10.1111/cpr.12611
|
| 50 |
Katharina Blatt, Harald Herrmann, Gabriele Stefanzl, Wolfgang R. Sperr, Peter Valent. Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myeloma. Oncotarget 2016; 7(40): 65627 doi: 10.18632/oncotarget.11593
|
| 51 |
Fieke W. Hoff, Anneke D. Van Dijk, Yihua Qiu, Chenyue W. Hu, Rhonda E. Ries, Andrew Ligeralde, Gaye N. Jenkins, Robert B. Gerbing, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Todd A. Alonzo, Soheil Meshinchi, Amina A. Qutub, Eveline S.J.M. De Bont, Terzah M. Horton, Steven M. Kornblau. Clinical relevance of proteomic profiling in <i>de novo</i> pediatric acute myeloid leukemia: a Children’s Oncology Group study. Haematologica 2022; 107(10): 2329 doi: 10.3324/haematol.2021.279672
|
| 52 |
Cristina Mambet, Mihaela Chivu-Economescu, Lilia Matei, Laura Georgiana Necula, Denisa Laura Dragu, Coralia Bleotu, Carmen Cristina Diaconu. Murine models based on acute myeloid leukemia-initiating stem cells xenografting. World Journal of Stem Cells 2018; 10(6): 57-65 doi: 10.4252/wjsc.v10.i6.57
|
| 53 |
Jianbiao Zhou, Sabrina Hui-Min Toh, Zit-Liang Chan, Jessie Yiying Quah, Jing-Yuan Chooi, Tuan Zea Tan, Phyllis S. Y. Chong, Qi Zeng, Wee-Joo Chng. A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase. Journal of Hematology & Oncology 2018; 11(1) doi: 10.1186/s13045-018-0581-9
|